Financial statements Apotessile
Balance sheet data of APOTESSILE
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|---|---|---|---|---|---|
Total assets | 7 085 035,91 | 4 489 564,74 | 5 332 263,16 | 6 389 121,33 | 5 671 678,12 | 8 381 825,50 |
A. Fixed assets | 2 566 101,70 | 2 331 531,02 | 2 300 101,81 | 3 616 957,94 | 3 534 384,83 | 5 973 356,92 |
B. Current assets | 4 518 934,21 | 2 158 033,72 | 3 032 161,35 | 2 772 163,39 | 2 137 293,29 | 2 408 468,58 |
C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
Total liabilities | 7 085 035,91 | 4 489 564,74 | 5 332 263,16 | 6 389 121,33 | 5 671 678,12 | 8 381 825,50 |
A. Equity | 1 752 603,50 | 2 122 249,59 | 2 539 492,43 | 2 971 555,35 | 3 391 322,42 | 4 003 939,09 |
B. Liabilities and provisions for liabilities | 145 511,48 | 2 367 315,15 | 2 792 770,73 | 3 417 565,98 | 2 280 355,70 | 4 377 886,41 |
I. Long-term liabilities | 0,00 | 0,00 | 0,00 | 0,00 | 1 253 351,56 | 2 643 718,42 |
II. Short-term liabilities | 5 186 920,93 | 2 315 066,67 | 2 792 770,73 | 3 417 565,98 | 1 027 004,14 | 1 734 167,99 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.